Syngene International Limited Bombay S.E.
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
696.5 INR | -0.11% | -0.61% | -0.61% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- SYNGENE Stock
- SYNGENE Stock
- News Syngene International Limited
- Syngene International Books Lower Consolidated Net Profit in Fiscal Q1